Table 3. Change in dose with respect to target BP achievement.

*p<0.05 was considered significant using Pearson Chi Square test

BP, blood pressure; Valsartan, Val; Amlodipine, Aml

Change in dosage	Target BP achieved  (less than 140/90)						p-value
	Week 1		Week 4		Week 8
	n	%	n	%	n	%
80/5 mg tablet (80 mg of Val and 5 mg of Aml)	155	88.6	202	82.1	192	75.6	<0.01*
160/5 mg tablet (160 mg of Val and 5 mg of Aml)	16	9.1	36	14.6	47	18.5	<0.01*
160/10 mg tablet (160 mg of Val and 10 mg of Aml)	4	2.3	8	3.3	15	5.9	<0.01*